Gene-Environment Interactions in Alzheimer's Disease
NCT00018473 · Status: COMPLETED · Type: OBSERVATIONAL
Last updated 2009-01-21
Summary
This study will create Alzheimer 's disease risk profiles for defined combinations of genotypes and environmental exposures. This study will carry out a molecular epidemiologic study to identify genetic and environmental risks factors using state of the art techniques. The following will be done during the course of this study 1) Recruit both Alzheimer's patients and cognitively normal aged veterans. 2) Evaluate gene interaction in Alzheimer's disease. 3) Evaluate gene-environment interactions on the risk of Alzheimer's disease. These procedures should initially address the question as to whether certain genes either independently or synergistically modify the risk of Alzheimer's disease. This study will also determine whether certain environmental factors (smoking, alcohol consumption etc.) can modify the risk of AD and whether this effect is dependent on certain genetic backgrounds. This study will provide information that will be useful in designing therapies, develop risk factor profiles to be further tested in future studies, designating patients for specific therapies based on genetic factors and providing data and genetic material for future studies. This study will also provide a cohort of older and well characterized cognitively normal veterans for prospective genetic epidemiological studies on aging.
Conditions
Sponsors & Collaborators
-
US Department of Veterans Affairs
lead FED
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 1999-04-30
- Completion
- 2004-03-31
Countries
- United States
Study Locations
More Related Trials
-
The Safety and Efficacy of an Investigational Drug in Delaying the Progression of Alzheimer's Disease
NCT00006187 ·Status: TERMINATED ·Phase: PHASE3
-
A Clinical Trial of AAV2-BDNF Gene Therapy in Early Alzheimer's Disease and Mild Cognitive Impairment
NCT05040217 ·Status: RECRUITING ·Phase: PHASE1
-
Donepezil and Brain Activity Patterns in Those at Risk For Alzheimer's Disease
NCT00408525 ·Status: COMPLETED ·Phase: PHASE1
-
The Study of microRNA 107 (miRNA 107) and Beta-amyloid Precursor Protein-cleaving Enzyme 1 (BACE1) Messenger Ribonucleic Acid (mRNA) Gene Expression in Cerebrospinal Fluid and Peripheral Blood of Alzheimer's Disease
NCT01819545 ·Status: UNKNOWN
-
Treatment of Language and Memory in Patients With Alzheimer's Disease
NCT00593372 ·Status: COMPLETED ·Phase: PHASE1
-
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.
NCT04623242 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
NCT06647498 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Electrophysiologic Measures of Treatment Response in Alzheimer Disease
NCT00018278 ·Status: COMPLETED ·Phase: PHASE4
-
Biodistribution of [11C]PIB in Patients With Risk Factors for Alzheimer's Disease
NCT03089827 ·Status: ENROLLING_BY_INVITATION
-
The Evaluation and Follow-up of Individuals With Memory Disorder
NCT00001480 ·Status: COMPLETED
-
A Long-Term Safety Extension of Studies ABE4869g and ABE4955g in Participants With Mild to Moderate Alzheimer's Disease Treated With Crenezumab
NCT01723826 ·Status: COMPLETED ·Phase: PHASE2
-
The Mechanism of MicroRNAs Network in Alzheimer's Disease
NCT05055310 ·Status: COMPLETED
-
The Use of Memantine for Prevention of Alzheimer's Disease
NCT05063851 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Phase 2 Estimation Study of Fixed Dose Drugs Combination Type of Polypill
NCT06597058 ·Status: COMPLETED ·Phase: PHASE2
-
Hyperhomocysteinemia in Alzheimer's Disease
NCT05793372 ·Status: NOT_YET_RECRUITING
-
Feasibility Trial of a Mediterranean Diet Pattern to Prevent Cognitive Decline
NCT02921672 ·Status: COMPLETED ·Phase: NA
-
Assessment of Clinical Trial Experiences of Alzheimer's Disease Patients
NCT05672732 ·Status: NOT_YET_RECRUITING
-
A Survey Study of the Treatment and Outcome Management in Patients Diagnosed With Alzheimer's Disease
NCT00291421 ·Status: COMPLETED
-
Efficacy and Safety of 26-Week Treatment of AR1001 in Patients With Mild to Moderate Alzheimer's Disease
NCT03625622 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Of PF-04447943 Compared To Placebo In Subjects With Mild To Moderate Alzheimer's Disease
NCT00930059 ·Status: COMPLETED ·Phase: PHASE2
-
APOE in the Predisposition to, Protection From, and Prevention of Alzheimer's Disease
NCT04994847 ·Status: ENROLLING_BY_INVITATION
-
Gene Therapy for Alzheimer's Disease Clinical Trial
NCT00017940 ·Status: COMPLETED ·Phase: PHASE1
-
Monitoring Drug Efficacy in Patients with Alzheimer's Disease
NCT05801380 ·Status: RECRUITING
-
Effectiveness of A Nutritional Brain Metabolic Enhancer for Alzheimer Disease
NCT00013923 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL593 in Healthy Participants and Participants With Frontotemporal Dementia (FTD-GRN)
NCT05262023 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2